CompletedPhase 3

A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

NCT03329508

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

P2B001/003 Site Scottsdale

Scottsdale, Arizona, United States

+71 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2018-01-19
Enrollment: 544 participants
Sponsor: Pharma Two B Ltd.
Purpose: treatment

Locations (72)

P2B001/003 Site ScottsdaleScottsdale, Arizona, United States
P2B001/003 study site ScottsdaleScottsdale, Arizona, United States
P2B001/003 Study site little RockLittle Rock, Arkansas, United States
P2B001 site Los AngelesLos Angeles, California, United States
P2B001 Study site Englewood,Englewood, Colorado, United States
P2B001 Study VernonVernon, Connecticut, United States
P2B001/003 site Boca RatonBoca Raton, Florida, United States
P2B001/003 Site Boca RatonBoca Raton, Florida, United States
P2B001/003 study site JacksonvilleJacksonville, Florida, United States
P2B001/003 site MiamiMiami, Florida, United States
P2B001/003 Site Port CharlottePort Charlotte, Florida, United States
P2B001/003 Site SarasotaSarasota, Florida, United States
P2B001/003 Site TampaTampa, Florida, United States
P2B001/003 Site AugustaAugusta, Georgia, United States
P2B001/003 study site HonoluluHonolulu, Hawaii, United States
P2B001/003 site ChicagoChicago, Illinois, United States
P2B001/003 Site WinfieldWinfield, Illinois, United States
P2B001/003 site Kansas CityKansas City, Kansas, United States
P2B001/003 Site LexingtonLexington, Kentucky, United States
P2B001/003 study site BostonBoston, Massachusetts, United States
P2B001/003 Site East LansingEast Lansing, Michigan, United States
P2B001/003 study site west BloomfieldWest Bloomfield, Michigan, United States
P2B001/003 Site Golden ValleyGolden Valley, Minnesota, United States
P2B001/003 site St. LouisSt Louis, Missouri, United States
P2B001/003 study site New HampshireLebanon, New Hampshire, United States
P2B001/003 Study site CamdenCamden, New Jersey, United States
P2B001 Study site EdisonEdison, New Jersey, United States
P2B001/003 Study site AlbuquerqueAlbuquerque, New Mexico, United States
P2B001/003 Study site BrooklynBrooklyn, New York, United States
P2B001/003 Site CommackCommack, New York, United States
P2B001/003 New YorkNew York, New York, United States
P2B001 Study site SyracuseSyracuse, New York, United States
P2B001/003 Study site WilliamsvilleWilliamsville, New York, United States
P2B001/003 Site AshevilleAsheville, North Carolina, United States
P2B001 study site CincinnatiCincinnati, Ohio, United States
P2B001/003 Site ToledoToledo, Ohio, United States
P2B001/003 Study site HersheyHershey, Pennsylvania, United States
P2B001/003 GreenvilleGreenville, South Carolina, United States
P2B0011/003 Study Veracity NeuroscienceMemphis, Tennessee, United States
p2B001/003 Study site MemphisMemphis, Tennessee, United States
P2B001/003 Study site NashvilleNashville, Tennessee, United States
P2B001/003 Site DallasDallas, Texas, United States
P2B001/003 Study site AlexandriaAlexandria, Virginia, United States
P2B001/003Falls Church, Virginia, United States
P2B001/003 Site KirklandKirkland, Washington, United States
P2B001/003 study site TorontoToronto, Ontario, Canada
P2B001/003 Study site FreiburgFreiburg im Breisgau, Baden-Wurttemberg, Germany
P2B001/003 study site UlmUlm, Baden-Wurttemberg, Germany
P2B001/003 study site HaagHaag, Bavaria, Germany
P2B001/003 Study site HaagHaag, Bavaria, Germany
P2B001/003 Study site MünchenMünchen, Bavaria, Germany
P2B001/003 Study site HanauHanau, Hesse, Germany
P2B001/003 Study site BochumBochum, North Rhine-Westphalia, Germany
P2B001/003 Study site MünsterMünster, North Rhine-Westphalia, Germany
P2B001/003 Study site DresdenDresden, SaACHSEN, Germany
P2B001/003 study site LeipzigLeipzig, Saxony, Germany
P2B001/003 study site Gera GermanyGera, Thuringia, Germany
P2B001/003 Study site GeraGera, Thuringia, Germany
P2B001/003 Study site BerlinBerlin, Germany
P2B001/003 Study site BerlinBerlin, Germany
P2B001/003 site MunichMunich, Germany
P2B001/003 Study site Sant Cugat del VallésSant Cugat Del Vallés, Barcelona, Spain
P2B001/003 study site MostolesMóstoles, Madridid, Spain
P2B001/003 Study site PamplonaPamplona, Navarre, Spain
P2B001/003 Study site La PazMadrid, S, Spain
P2B001/003 Study site BarcelonaBarcelona, Spain
P2B001/003 Study site Vall d'HebrónBarcelona, Spain
P2B001/003 Study site Navarra MadridMadrid, Spain
P2B001/003 study site MadridMadrid, Spain
P2B001/003 Study site MadridMadrid, Spain
P2B0011/003 Study site HM Centro Integral de Neurociencias (CINAC)Madrid, Spain
P2B001/003 Study site Puerta de Hierro - MajadahondaMajadahonda, Spain